Finnrick

Finnrick Analytics is an independent peptide testing company on a mission to bring transparency and accountability to the health and wellness supply chains where people increasingly seek products outside of regulated channels. Based in Austin, Texas, Finnrick protects the public by testing peptides and exposing supply chain failures through a unique crowd-sourced testing model.

The company has tested over 8,779 samples from 263 vendors across 15 popular peptides, creating the largest real-world dataset of peptide quality ever assembled. Finnrick offers free testing to the public - anyone can mail in a vial for independent laboratory analysis, with results published in a public, ranked database. They also procure samples directly from vendors to ensure consistent and unbiased testing.

Unlike typical testing services, Finnrick doesn't sell peptides, provide medical advice, or accept payment to modify ratings. Instead, they work with multiple independent analytical laboratories including Krause Analytical, BTLabs, Chromate, TrustPointe, Freedom Diagnostics, Janoshik, and MZ Biolabs to cross-validate results. The company is backed by notable investors including Naval Ravikant and is led by CEO Raphaël Mazoyer, Chairman Michael Carter, and Stephanie Adamson King handling Policy & Platforms.